Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Jul 18, 2022

SELL
$0.27 - $0.5 $13,500 - $25,000
-50,000 Closed
0 $0
Q1 2022

Apr 12, 2022

BUY
$0.37 - $0.54 $18,500 - $27,000
50,000 New
50,000 $1.42 Million

Others Institutions Holding PTN

# of Institutions
1
Shares Held
2.94K
Call Options Held
0
Put Options Held
0

About PALATIN TECHNOLOGIES INC


  • Ticker PTN
  • Exchange NYSE
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 9,290,480
  • Market Cap $7.34M
  • Description
  • Palatin Technologies, Inc., a biopharmaceutical company, develops targeted receptor-specific therapeutics for the treatment of various diseases in the United States. The company's lead product is Vyleesi, a melanocortin receptor (MCr) agonist for the treatment of premenopausal women with hypoactive sexual desire disorder. It is also developing o...
More about PTN
Track This Portfolio

Track Connective Portfolio Management, LLC Portfolio

Follow Connective Portfolio Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Connective Portfolio Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Connective Portfolio Management, LLC with notifications on news.